RXO Is Maintained at Neutral by UBS
RXO Is Maintained at Neutral by Goldman Sachs
Goldman Sachs Maintains Neutral on RXO, Lowers Price Target to $18
RXO Is Maintained at Hold by Stifel
RXO Is Maintained at Equal-Weight by Wells Fargo
RXO Analyst Ratings
Barclays Maintains RXO Inc(RXO.US) With Buy Rating, Cuts Target Price to $18
Morgan Stanley Maintains RXO Inc(RXO.US) With Hold Rating, Cuts Target Price to $23
Truist Financial Maintains RXO Inc(RXO.US) With Buy Rating, Cuts Target Price to $19
RXO Analyst Ratings
Benchmark Co. Maintains RXO Inc(RXO.US) With Hold Rating
Jefferies Maintains RXO Inc(RXO.US) With Buy Rating, Cuts Target Price to $20
RXO Is Maintained at Buy by Jefferies
Jefferies Maintains Buy on RXO, Lowers Price Target to $20
RXO Is Maintained at Neutral by Goldman Sachs
Goldman Sachs Maintains RXO Inc(RXO.US) With Hold Rating, Cuts Target Price to $21
Goldman Sachs Remains a Hold on RXO, Inc. (RXO)
RXO Is Maintained at Neutral by Citigroup
RXO Price Target Cut to $15.00/Share From $23.00 by Citigroup
RXO Analyst Ratings